Dual Promoters Improve the Rescue of Recombinant Measles Virus in Human Cells

Dual Promoters Improve the Rescue of Recombinant Measles Virus in Human Cells

Reverse genetics is a technology that allows the production of a virus from its complementary DNA (cDNA). It is a powerful tool for analyzing viral genes, the development of novel vaccines, and gene delivery vectors. The standard reverse genetics protocols are laborious, time-consuming, and ineffici...

Full description

Bibliographic Details
Main Authors:	Soroth Chey, Juliane Maria Palmer, Laura Doerr, Uwe Gerd Liebert
Format:	Article
Language:	English
Published:	MDPI AG 2021-08-01
Series:	Viruses
Subjects:	measles virus reverse genetics negative-strand RNA virus recombinant virus multivalent vaccines oncolytic vectors
Online Access:	https://www.mdpi.com/1999-4915/13/9/1723

Similar Items

Measles to the Rescue: A Review of Oncolytic Measles Virus
by: Sarah Aref, et al.
Published: (2016-10-01)

Mutated Measles Virus Matrix and Fusion Protein Influence Viral Titer In Vitro and Neuro-Invasion in Lewis Rat Brain Slice Cultures
by: Johannes Busch, et al.
Published: (2021-04-01)

The Susceptibility of Human Melanoma Cells to Infection with the Leningrad-16 Vaccine Strain of Measles Virus
by: Yulia Ammour, et al.
Published: (2020-02-01)

Measles Virus as an Oncolytic Immunotherapy
by: Christine E. Engeland, et al.
Published: (2021-02-01)

Transcriptome Analysis of Human Glioblastoma Cells Susceptible to Infection with the Leningrad-16 Vaccine Strain of Measles Virus
by: Yulia Ammour, et al.
Published: (2022-11-01)

MECHANISMS AND CLINICAL EFFECTS OF DRUGS BASED ON ONCOLYTIC ADENOVIRUSES, HERPES VIRUSES, REOVIRUSES AND MEASLES VIRUS
by: A. P. Cherniakova, et al.
Published: (2020-12-01)

Recombinant Measles AIK-C Vaccine Strain Expressing Influenza HA Protein
by: Takashi Ito, et al.
Published: (2020-03-01)

A Combined Ultrafiltration/Diafiltration Process for the Purification of Oncolytic Measles Virus
by: Daniel Loewe, et al.
Published: (2022-01-01)

Oncolytic Measles Virus Encoding MicroRNA for Targeted RNA Interference
by: Sophie C. Anker, et al.
Published: (2023-01-01)

Graphene oxide arms oncolytic measles virus for improved effectiveness of cancer therapy
by: Mao Xia, et al.
Published: (2019-09-01)

Immunological Effects and Viral Gene Expression Determine the Efficacy of Oncolytic Measles Vaccines Encoding IL-12 or IL-15 Agonists
by: Paul S. Backhaus, et al.
Published: (2019-10-01)

Prospects for Using Expression Patterns of Paramyxovirus Receptors as Biomarkers for Oncolytic Virotherapy
by: Olga V. Matveeva, et al.
Published: (2020-12-01)

A novel cancer vaccine for melanoma based on an approved vaccine against measles, mumps, and rubella
by: Manlio Fusciello, et al.
Published: (2022-06-01)

Measles Cases during Ebola Outbreak, West Africa, 2013–2106
by: Francesca Colavita, et al.
Published: (2017-06-01)

Engineered measles virus Edmonston strain used as a novel oncolytic viral system against human hepatoblastoma
by: Zhang Shu-Cheng, et al.
Published: (2012-09-01)

Role of homologous recombination/recombineering on human adenovirus genome engineering: Not the only but the most competent solution
by: Lisa-Marie Dawson, et al.
Published: (2024-03-01)

Establishment of Recombinant Trisegmented Mopeia Virus Expressing Two Reporter Genes for Screening of Mammarenavirus Inhibitors
by: Lisa Oestereich, et al.
Published: (2022-08-01)

Combination of Oncolytic Measles Virus Armed With BNiP3, a Pro-apoptotic Gene and Paclitaxel Induces Breast Cancer Cell Death
by: Geetanjali Lal, et al.
Published: (2019-01-01)

Oncolytic measles virus encoding interleukin-12 mediates potent antitumor effects through T cell activation
by: Rūta Veinalde, et al.
Published: (2017-04-01)

Measles Epidemics Among Children in Vietnam: Genomic Characterization of Virus Responsible for Measles Outbreak in Ho Chi Minh City, 2014
by: Van H. Pham, et al.
Published: (2014-12-01)

Ursolic Acid and Its Nanoparticles Are Potentiators of Oncolytic Measles Virotherapy against Breast Cancer Cells
by: Ching-Hsuan Liu, et al.
Published: (2021-01-01)

Performance Evaluation of the VIDAS® Measles IgG Assay and Its Diagnostic Value for Measuring IgG Antibody Avidity in Measles Virus Infection
by: Julia Dina, et al.
Published: (2016-08-01)

Combination of Oncolytic Measles Virus and Ursolic Acid Synergistically Induces Oncolysis of Hepatocellular Carcinoma Cells
by: Ching-Hsuan Liu, et al.
Published: (2023-05-01)

Virotheranostics, a double-barreled viral gun pointed toward cancer; ready to shoot?
by: Mohsen Keshavarz, et al.
Published: (2020-04-01)

Chimeric Measles Virus (MV/RSV), Having Ectodomains of Respiratory Syncytial Virus (RSV) F and G Proteins Instead of Measles Envelope Proteins, Induced Protective Antibodies against RSV
by: Akihito Sawada, et al.
Published: (2021-02-01)

Oncolytic Virus with Attributes of Vesicular Stomatitis Virus and Measles Virus in Hepatobiliary and Pancreatic Cancers
by: Bolni Marius Nagalo, et al.
Published: (2020-09-01)

Cell tropism and pathogenesis of measles virus in monkeys
by: Sei-ich eKato, et al.
Published: (2012-01-01)

Oncolytic measles vaccines encoding PD-1 and PD-L1 checkpoint blocking antibodies to increase tumor-specific T cell memory
by: Rūta Veinalde, et al.
Published: (2022-03-01)

Rescue and characterization of recombinant cedar virus, a non-pathogenic Henipavirus species
by: Eric D. Laing, et al.
Published: (2018-03-01)

Level of measles herd immunity assessed in hospital medical workers within a framework of the state measles elimination program
by: M. P. Kostinov, et al.
Published: (2020-04-01)

Measles Outbreak, the Netherlands, 2008
by: Susan Hahné, et al.
Published: (2010-03-01)

Use of a Diagonal Approach to Health System Strengthening and Measles Elimination after a Large Nationwide Outbreak in Mongolia
by: José E. Hagan, et al.
Published: (2017-12-01)

Evaluation of anti-measles and anti-mumps vaccination coverage in a cohort of youth in South-Centre of Sicily, Italy
by: Claudia Lo Magno, et al.
Published: (2015-12-01)

Measles: A disease that’s making a comeback
by: Małgorzata Bojarska, et al.
Published: (2022-08-01)

Molecular characterisation of the emerging measles virus from Roraima state, Brazil, 2018
by: Cátia Alexandra Ribeiro Meneses, et al.
Published: (2019-03-01)

Measles situation in Serbia in an era of measles elimination (2007-2009)
by: Nedeljković Jasminka, et al.
Published: (2013-01-01)

Oncolytic Viral Therapy for Mesothelioma
by: Daniel F. Pease, et al.
Published: (2017-08-01)

Measles virus hemagglutinin: structural insights into cell entry and measles vaccine
by: Takao eHashiguchi, et al.
Published: (2011-12-01)

Recombinant influenza A viruses as vaccine vectors
by: Thomas Gerlach, et al.
Published: (2019-04-01)

Cytoskeletal Dynamics: Concepts in Measles Virus Replication and Immunomodulation
by: Sibylle Schneider-Schaulies, et al.
Published: (2011-01-01)